Furthermore, 72 CSRs showed higher expression in breast tumours versus non-breast healthy tissues, including VTCN1 (log2FC = 7.0), LRRC (5.8), and SLITRK6 (5.5) (Fig 2D). This evidence concerns the gene VTCN1 and breast neoplasm.